14.2 Home Nutrition Support (HNS) & Care Transitions

14.2 Home Nutrition Support (HNS) & Care Transitions

Clinical Core: Safe home enteral nutrition (HEN) and home parenteral nutrition (HPN) depend on much more than writing a discharge formula. The team must verify the ongoing indication, metabolic and hemodynamic stability, vascular or enteral access, patient or caregiver competency, a safe home environment, coverage and supply continuity, and a named clinician who will review laboratory results and adjust therapy.

Candidate and Environment Assessment

A candidate should have a continuing need that cannot be met safely by ordinary oral intake, a regimen that can be delivered in the home, and clinical stability sufficient for outpatient management. Before discharge, confirm that acute electrolyte and glucose problems are controlled, the access device functions, and the patient is tolerating a reproducible regimen.

The patient or caregiver must demonstrate—not merely verbalize—hand hygiene, aseptic or clean technique appropriate to the therapy, pump setup, medication separation, flushing, storage, troubleshooting, and emergency response. Evaluate vision, dexterity, cognition, language, health literacy, refrigeration, clean water, electricity, telephone access, transportation, and the availability of backup supplies. Arrange interpreter and accessible-format support when needed.

Transition Checklist

Use closed-loop communication: the receiving clinician, home infusion pharmacy, nursing agency, patient, and caregiver should receive the same final prescription. Medication reconciliation must identify drugs that cannot be crushed, drugs that interact with formula, and drugs added to or administered separately from PN.

Cycling Parenteral Nutrition

Cyclic PN delivers the daily prescription over fewer than 24 hours, often overnight, to permit mobility and an infusion-free period. It may be useful for long-term home therapy, but it is not mandatory for every patient. Cycle length is individualized to age, dextrose load, glucose tolerance, fluid tolerance, liver disease, lifestyle, and pump capability.

Some patients require gradual compression over several days. A ramp-up or ramp-down may be used when a patient has prior glucose instability, is very young, receives a high glucose infusion rate, or has symptoms when an infusion starts or stops. It is inaccurate to prescribe a universal one-hour taper as essential for every stable adult. Follow the home-infusion protocol, check glucose when clinically indicated, and teach treatment of symptomatic hypoglycemia. If PN is interrupted unexpectedly, the response depends on symptoms, glucose concentration, insulin exposure, and the expected duration of interruption.

Patient and Caregiver Education

Use demonstration and teach-back for every high-risk skill. Education should cover:

1. Hand hygiene and a clean work surface.
2. Product inspection for leaks, particles, precipitate, separation, damage, or an incorrect label.
3. Refrigerated storage when required and removal from refrigeration according to supplier instructions.
4. Pump programming, tubing and filter setup, connection, disconnection, flushing, and disposal.
5. Catheter or tube site assessment and dressing or stoma care.
6. Recognition of fever, chills, dyspnea, edema, dehydration, tube dislodgement, leakage, occlusion, or pump failure.
7. Which number to call during business hours and after hours, and which findings require emergency services.

Competency is documented when the learner independently performs the full sequence and explains the emergency plan. Provide plain-language, language-concordant written instructions that exactly match the equipment and product supplied at home.

Monitoring After Discharge

Early follow-up is more frequent while the regimen and fluid/electrolyte balance stabilize. Monitor weight trend, hydration, intake and output when relevant, access-device condition, actual delivered volume, gastrointestinal tolerance, functional status, and progress toward goals. Laboratory selection and frequency are individualized; commonly reviewed measures include electrolytes, glucose, renal function, magnesium, phosphorus, liver tests, triglycerides for PN, blood count, and selected micronutrients during long-term therapy.

Every result needs an owner and an action threshold. A laboratory order without a designated reviewer is an unsafe transition. Reassess whether the original route and dose remain necessary as oral or enteral tolerance improves.

Current Medicare Coverage Framework

The former national coverage determination for enteral and parenteral nutritional therapy, NCD 180.2, was retired effective April 10, 2023. Coverage is now operationalized through the applicable Durable Medical Equipment Medicare Administrative Contractor local coverage determination and policy article, including LCD L38953 and Article A58836 where applicable. Clinicians must check the current policy for the beneficiary’s jurisdiction rather than citing the retired NCD as active.

Under current policy, the treating practitioner must document why the impairment prevents food from reaching or being absorbed from the small bowel and why enteral nutrition has been considered, ruled out, failed, or would exacerbate the gastrointestinal dysfunction when PN is requested. The record must support the prescribed nutrients, route, frequency, duration, and medical necessity.

The prosthetic-device benefit uses “permanent” to mean that the treating practitioner expects the impairment to be of long and indefinite duration. Current policy does not define permanence as a universal minimum of 90 days. Coverage decisions are documentation- and policy-specific; a clinician should never promise payment based only on diagnosis or an invented duration threshold.